Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 5Head & Neck 3Breast 3Plasma cell 2Other solid neoplasm 2Lymphoid 2Gynecologic 2CNS 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Genitourinary 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Papillomavirus Infections 1Mesothelioma, Malignant 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Referral and Consultation × Gynecologic × Clear all
NCT02067507 2019-10-25

Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County

University of California, Los Angeles

Phase NA Completed
53,414 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01126346 2018-07-03

HOPE

Wake Forest University Health Sciences

Phase NA Completed
10 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡